Ovarian tissues were examined for growthdifferentiation factor 9 and bone morphogenetic protein15 using immunofluorescent labelling and electronmicroscopic examinations.Results: The immunoreactivity of growth differentiationfactor 9 and bone morphogenetic protein 15 proteinsdecreased (p
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Background: Polycystic ovary syndrome is the mostfrequently seen endocrine disorder in women ofreproductive age with a prevalence of about 10%.Aims: To investigate the efficiency of growthdifferentiation factor 9 and bone morphogenetic protein15 during folliculogenesis in a dehydroepiandrosteroneinducedmouse Polycystic ovary syndrome model.Study Design: Animal experimentation.Methods: Mice were divided into 3 groups: control,vehicle and Polycystic ovary syndrome.
📊
Key Findings & Data:Polycysticovary syndrome model mice were developed by theinjection of dehydroepiandrosterone dissolved in 0.1 mLof sesame oil.
💡
Conclusion & Impact:Ovarian tissues were examined for growthdifferentiation factor 9 and bone morphogenetic protein15 using immunofluorescent labelling and electronmicroscopic examinations.Results: The immunoreactivity of growth differentiationfactor 9 and bone morphogenetic protein 15 proteinsdecreased (p
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
Background: Polycystic ovary syndrome is the mostfrequently seen endocrine disorder in women ofreproductive age with a prevalence of about 10%.Aims: To investigate the efficiency of growthdifferentiation factor 9 and bone morphogenetic protein15 during folliculogenesis in a dehydroepiandrosteroneinducedmouse Polycystic ovary syndrome model.Study Design: Animal experimentation.Methods: Mice were divided into 3 groups: control,vehicle and Polycystic ovary syndrome. Polycysticovary syndrome model mice were developed by theinjection of dehydroepiandrosterone dissolved in 0.1 mLof sesame oil. Ovarian tissues were examined for growthdifferentiation factor 9 and bone morphogenetic protein15 using immunofluorescent labelling and electronmicroscopic examinations.Results: The immunoreactivity of growth differentiationfactor 9 and bone morphogenetic protein 15 proteinsdecreased (p
🔖
Cite This Article
YILMAZ, B. C., OREKİCİ, G. T., AKTAŞ, S., KARAGÜL, M. İ., YILMAZ, M. (2022). GDF9 and BMP15 Expressions and Fine Structure Changes During Folliculogenesis in Polycystic Ovary Syndrome. Balkan Medical Journal, Cilt: 35 - Sayı: 1, 43–54. https://ajindex.com/articles/461049
Daniilidis A, Dinas K. Long term health consequences of polycystic ovarian syndrome: a review analysis. Hippokratia 2009;13:90-2.
Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol 2011;7:219-31.
Dumesic DA, Abbott DH, Padmanabhan V. Polycystic ovary syndrome and its developmental origins. Rev Endocr Metab Disord 2007;8:127-41.
Oktem O, Urman B. Understanding follicle growth in vivo. Hum Reprod 2010;25:2944-54.
Elvin JA, Yan C, Matzuk MM. Oocyte-expressed TGF-beta superfamily members in female fertility. Mol Cell Endocrinol 2000;159:1-5.
Dumesic DA, Abbott DH. Implications of polycystic ovary syndrome on oocyte development. Semin Reprod Med 2008;26:53-61.
Peng J, Li Q, Wigglesworth K, Rangarajan A, Kattamuri C, Peterson RT, et al. Growth differentiation factor 9: bone morphogenetic protein 15 heterodimers are potent regulators of ovarian functions. Proc Natl Acad Sci U S A 2013;110:E776-85. de Resende LO, Vireque AA, Santana LF, Moreno DA, de Sá Rosa e Silva AC, Ferriani RA, et al. Single-cell expression analysis of BMP15 and GDF9 in mature oocytes and BMPR2 in cumulus cells of women with polycystic ovary syndrome undergoing controlled ovarian hyperstimulation. J Assist Reprod Genet 2012;29:1057-65.
Wei LN, Li LL, Fang C, Huang R, Liang XY. Inhibitory effects of controlled ovarian stimulation on the expression of GDF9 and BMP15 in oocytes from women with PCOS. J Assist Reprod Genet 2013;30:1313-18.
Otsuka F, McTavish KJ, Shimasaki S. Integral role of GDF-9 and BMP-15 in ovarian function. Mol Reprod Dev 2011;78:9-21.
Carabatsos MJ, Elvin J, Matzuk MM, Albertini DF. Characterization of oocyte and follicle development in growth differentiation factor-9-deficient mice. Dev Biol 1998;204:373-84.
Wu YT, Tang L, Cai J, Lu XE, Xu J, Zhu XM, et al. High bone morphogenetic protein-15 level in follicular fluid is associated with high quality oocyte and subsequent embryonic development. Hum Reprod 2007;22:1526-31.
Zhao SY, Qiao J, Chen YJ, Liu P, Li J, Yan J. Expression of growth differentiation factor-9 and bone morphogenetic protein-15 in oocytes and cumulus granulosa cells of patients with polycystic ovary syndrome. Fertil Steril 2010;94:261-7.
Wei LN, Liang XY, Fang C, Zhang MF. Abnormal expression of growth differentiation factor 9 and bone morphogenetic protein 15 in stimulated oocytes during maturation from women with polycystic ovary syndrome. Fertil Steril 2011;96:464-8. Wei LN,